WASHINGTON, Sept 5 (Reuters) - Warner Chilcott Holdings Company Ltd., which makes prescription drugs for women’s health care, on Tuesday set its planned initial public offering at 70.6 million Class A shares at an estimated price of $17 to $19 per share.
